← FDA DRUG APPROVALS

FDA ANDA · ANDA040117

VICODIN HP

Sponsor: ABBVIE

APPLICATION
ANDA040117
TYPE
ANDA
ORIGINAL APPROVAL
1996-09-23
LATEST ACTION
2001-05-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

VICODIN HPDiscontinued
ACETAMINOPHEN 660MG, HYDROCODONE BITARTRATE 10MG · TABLET · ORAL

Approval history

2001-05-01Manufacturing (CMC) · Supplement 3AP
2000-06-27Manufacturing (CMC) · Supplement 2AP
2000-02-15Manufacturing (CMC) · Supplement 1AP
1996-09-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →